DEUTSCHE BANK AG\ - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 58 filers reported holding VIRACTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$12,606
-45.6%
7,928
-50.1%
0.00%
Q4 2022$23,188
-65.9%
15,8820.0%0.00%
Q3 2022$68,000
+9.7%
15,8820.0%0.00%
Q2 2022$62,000
-34.0%
15,882
-19.3%
0.00%
Q1 2022$94,000
+17.5%
19,681
-10.6%
0.00%
Q4 2021$80,000
-52.1%
22,019
+5.6%
0.00%
Q3 2021$167,000
-31.6%
20,853
-3.1%
0.00%
Q2 2021$244,00021,5240.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$1,120,0000.80%
Samsara BioCapital, LLC 689,709$2,676,0000.71%
BVF INC/IL 3,614,662$14,025,0000.68%
HAMILTON LANE ADVISORS LLC 71,491$277,0000.11%
MAI Capital Management 647,950$2,514,0000.05%
Laurion Capital Management LP 698,000$2,708,0000.04%
Jasper Ridge Partners, L.P. 92,939$361,0000.02%
BOURGEON CAPITAL MANAGEMENT LLC 20,500$80,0000.02%
Ergoteles LLC 155,562$604,0000.02%
Clear Harbor Asset Management, LLC 25,000$97,0000.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders